EVOLUS, INC.
EOLS US30052C1071
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 103% | 7% | 34% | 11% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Yamagishi-dressler Tomoko CMO |
7.51 USD |
5,722 Sold |
42,972 USD |
22/08/2025 | 22/08/2025 |
| Stewart Brady |
6.82 USD |
30,000 Bought |
204,486 USD |
15/08/2025 | 15/08/2025 |
| Moatazedi David O |
9.89 USD |
16,582 Sold |
164,054 USD |
13/06/2025 | 16/06/2025 |
| Moatazedi David O |
9.89 USD |
16,582 Sold |
164,054 USD |
13/06/2025 | 16/06/2025 |
| Moatazedi David O |
10.05 USD |
111,323 Sold |
1,119,141 USD |
13/06/2025 | 13/06/2025 |
| Moatazedi David O |
10.05 USD |
111,323 Sold |
1,119,141 USD |
13/06/2025 | 13/06/2025 |
| White Albert G Iii |
9.45 USD |
20,000 Bought |
189,000 USD |
09/06/2025 | 09/06/2025 |
| Beaver Sandra CFO |
10.02 USD |
6,494 Sold |
65,070 USD |
13/05/2025 | 13/05/2025 |
| Beaver Sandra CFO |
10.02 USD |
6,494 Sold |
65,070 USD |
13/05/2025 | 13/05/2025 |
| Moatazedi David O |
9.87 USD |
15,787 Sold |
155,756 USD |
12/05/2025 | 12/05/2025 |